Terms: = Gastric cancer AND SET, I2PP2A, 6418, ENSG00000119335, TAF-IBETA, PHAPII, IGAAD, 2PP2A AND Prognosis
511 results:
1. High-Throughput Metabolic Pattern Screening Strategy for Early Colorectal and gastric cancers Based on Covalent Organic Frameworks-Assisted Laser Desorption/Ionization Mass Spectrometry.
Yang C; Yu H; Li W; Lin H; Wu H; Deng C
Anal Chem; 2024 Apr; 96(16):6264-6274. PubMed ID: 38600676
[TBL] [Abstract] [Full Text] [Related]
2. GGT5 facilitates migration and invasion through the induction of epithelial-mesenchymal transformation in gastric cancer.
Luo Z; Chen Y; Chen B; Zhao Z; Wu R; Ren J
BMC Med Genomics; 2024 Apr; 17(1):82. PubMed ID: 38581025
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic value and potential function of a novel heme-related LncRNAs signature in gastric cancer.
Ma S; Liao W; Chen Y; Gan L
Cell Signal; 2024 Jun; 118():111152. PubMed ID: 38548123
[TBL] [Abstract] [Full Text] [Related]
4. Exploration of signature based on T cell-related genes in stomach adenocarcinoma by analysis of single cell sequencing data.
Wang H; An N; Pei A; Sun Y; Li S; Chen S; Zhang N
Aging (Albany NY); 2024 Mar; 16(7):6035-6053. PubMed ID: 38536020
[TBL] [Abstract] [Full Text] [Related]
5. First-line camrelizumab (a PD-1 inhibitor) plus apatinib (an VEGFR-2 inhibitor) and chemotherapy for advanced gastric cancer (SPACE): a phase 1 study.
Chen X; Xu H; Chen X; Xu T; Tian Y; Wang D; Guo F; Wang K; Jin G; Li X; Wang R; Li F; Ding Y; Tang J; Fang Y; Zhao J; Liu L; Ma L; Meng L; Hou Z; Zheng R; Liu Y; Guan N; Zhang B; Tong S; Chen S; Li X; Shu Y
Signal Transduct Target Ther; 2024 Mar; 9(1):73. PubMed ID: 38528050
[TBL] [Abstract] [Full Text] [Related]
6. Validation of CDC45 as a novel biomarker for diagnosis and prognosis of gastric cancer.
Wu L; Gao G; Mi H; Luo Z; Wang Z; Liu Y; Wu L; Long H; Shen Y
PeerJ; 2024; 12():e17130. PubMed ID: 38515458
[TBL] [Abstract] [Full Text] [Related]
7. Construction of a gene model related to the prognosis of patients with gastric cancer receiving immunotherapy and exploration of COX7A1 gene function.
Wang SY; Wang YX; Shen A; Yang XQ; Liang CC; Huang RJ; Jian R; An N; Xiao YL; Wang LS; Zhao Y; Lin C; Wang CP; Yuan ZP; Yuan SQ
Eur J Med Res; 2024 Mar; 29(1):180. PubMed ID: 38494472
[TBL] [Abstract] [Full Text] [Related]
8. Novel metabolic biomarker for early detection and diagnosis to the patients with gastric cardia adenocarcinoma.
Wei MX; Yang Z; Wang PP; Zhao XK; Song X; Xu RH; Hu JF; Zhong K; Lei LL; Han WL; Yang MM; Zhou FY; Han XN; Fan ZM; Li J; Wang R; Li B; Wang LD
Cancer Med; 2024 Mar; 13(5):e7015. PubMed ID: 38491808
[TBL] [Abstract] [Full Text] [Related]
9. A predictive model for intraabdominal infection after radical gastrectomy in elderly patients.
Yu X; Tang W; Bai C; Li R; Feng B; Wu J; Guo X; Chen H; Li M
Medicine (Baltimore); 2024 Mar; 103(11):e37489. PubMed ID: 38489739
[TBL] [Abstract] [Full Text] [Related]
10. Machine learning-based cell death signature for predicting the prognosis and immunotherapy benefit in stomach adenocarcinoma.
Li F; Feng Q; Tao R
Medicine (Baltimore); 2024 Mar; 103(10):e37314. PubMed ID: 38457593
[TBL] [Abstract] [Full Text] [Related]
11. Perioperative or neoadjuvant chemotherapy for locally advanced gastric or gastroesophageal junction cancer: from independent evidence in the West, the East, and Japan to global collaboration.
Nakayama I; Ohashi M; Nunobe S
Chin Clin Oncol; 2024 Feb; 13(1):8. PubMed ID: 38453658
[TBL] [Abstract] [Full Text] [Related]
12. Risk factors, prognostic factors, and nomograms for distant metastases in patients with gastroenteropancreatic neuroendocrine tumors: a population-based study.
Li X; Fan Y; Tong J; Lou M
Front Endocrinol (Lausanne); 2024; 15():1264952. PubMed ID: 38449852
[TBL] [Abstract] [Full Text] [Related]
13. Prognostic value of RNA methylation-related genes in gastric adenocarcinoma based on bioinformatics.
He X; Chen X; Yang C; Wang W; Sun H; Wang J; Fu J; Dong H
PeerJ; 2024; 12():e16951. PubMed ID: 38436027
[TBL] [Abstract] [Full Text] [Related]
14. Metabolomic machine learning predictor for diagnosis and prognosis of gastric cancer.
Chen Y; Wang B; Zhao Y; Shao X; Wang M; Ma F; Yang L; Nie M; Jin P; Yao K; Song H; Lou S; Wang H; Yang T; Tian Y; Han P; Hu Z
Nat Commun; 2024 Feb; 15(1):1657. PubMed ID: 38395893
[TBL] [Abstract] [Full Text] [Related]
15. Expression patterns of E2Fs identify tumor microenvironment features in human gastric cancer.
Li F; Yan J; Leng J; Yu T; Zhou H; Liu C; Huang W; Sun Q; Zhao W
PeerJ; 2024; 12():e16911. PubMed ID: 38371373
[TBL] [Abstract] [Full Text] [Related]
16. TRANSCRIPTOME ANALYSIS REVEALED THE MOLECULAR SIGNATURES OF CISPLATIN-FLUOROURACIL COMBINED CHEMOTHERAPY RESISTANCE IN gastric cancer.
Luo Y; Chen X; Hu E; Wang L; Yang Y; Jiang X; Zheng K; Wang L; Li J; Xu Y; Wang Y; Xie Y
Georgian Med News; 2023 Dec; (345):6-18. PubMed ID: 38325291
[TBL] [Abstract] [Full Text] [Related]
17. GPX3-Mediated Oxidative Stress Affects Pyrimidine Metabolism Levels in Stomach Adenocarcinoma via the AMPK/mTOR Pathway.
Zhang Y; Yang Y; Kuang S; Zhang Y; Qin H; Xie J
Int J Clin Pract; 2024; 2024():6875417. PubMed ID: 38322113
[TBL] [Abstract] [Full Text] [Related]
18. A ubiquitination-related risk model for predicting the prognosis and immunotherapy response of gastric adenocarcinoma patients.
Shao S; Sun Y; Zhao D; Tian Y; Yang Y; Luo N
PeerJ; 2024; 12():e16868. PubMed ID: 38313020
[TBL] [Abstract] [Full Text] [Related]
19. Identification of necroptosis-associated miRNA signature for predicting prognosis and immune landscape in stomach adenocarcinoma.
Zhang S; Liu S; Yue C; Liu Y; Zheng G; Zhang Y
Exp Cell Res; 2024 Mar; 436(1):113948. PubMed ID: 38307189
[TBL] [Abstract] [Full Text] [Related]
20. Bioinformatics analysis identifies coagulation factor II receptor as a potential biomarker in stomach adenocarcinoma.
Wu X; Wang S; Wang C; Wu C; Zhao Z
Sci Rep; 2024 Jan; 14(1):2468. PubMed ID: 38291086
[TBL] [Abstract] [Full Text] [Related]
[Next]
